Rosetta Genomics Signs Two Deals for MicroRNA Tests

Rosetta signed agreements with Tel Hashomer Medical Research Infrastructure and Services and Carmel Medical Center to develop and validate Rosetta's miRNA-based tests for indications related to its Gen 3 products.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories